Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.00
+0.26 (1.05%)
At close: May 29, 2026, 4:00 PM EDT
24.85
-0.15 (-0.60%)
After-hours: May 29, 2026, 6:34 PM EDT

Pulse Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7309311,148675103440
Market Cap Growth
57.78%-18.85%70.05%554.41%-76.56%-27.81%
Enterprise Value
1,669856.661,037638.6852.06421.96
Last Close Price
25.0013.7317.4112.242.7714.81
PS Ratio
2303.92---147.34310.36
PB Ratio
25.7311.559.9915.22-45.8812.33
P/TBV Ratio
25.5011.478.8513.72-41.8111.60
EV/Sales Ratio
2222.48---74.38297.57
Debt / Equity Ratio
0.080.070.070.18-4.480.29
Net Debt / Equity Ratio
-0.92-0.91-0.95-0.7922.32-0.49
Net Debt / EBITDA Ratio
0.790.971.980.830.890.28
Net Debt / FCF Ratio
1.101.352.991.061.060.32
Asset Turnover
-0000.010.03
Inventory Turnover
5.327.93--4.100.68
Quick Ratio
6.9910.2211.746.6110.223.37
Current Ratio
7.2610.5311.886.7610.394.30
Return on Equity (ROE)
-26.09%-70.14%-63.93%-200.46%-349.89%-217.33%
Return on Assets (ROA)
-88.61%-67.79%-58.72%-63.60%-87.88%-131.91%
Return on Invested Capital (ROIC)
-1240.29%-1168.13%-757.11%-401.44%-375.63%-392.40%
Return on Capital Employed (ROCE)
-98.52%-73.62%-64.35%-70.09%-98.71%-158.65%
Buyback Yield / Dilution
-11.03%-15.41%-17.41%-46.57%-21.35%-20.29%
Total Shareholder Return
-11.03%-15.41%-17.41%-46.57%-21.35%-20.29%
SEC Filings: 10-K · 10-Q